Citations

Clear

6274 citation(s) found for "To, Andrew".

Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair
Abeykoon, Jithma P. , Wu, Xiaosheng , Nowakowski, Kevin E., Dasari, Surendra , Paludo, Jonas , Weroha, S. John , Hou, Xiaonan , Mladek, Ann C. , Phillips, Jessica L. , Ravindran, Aishwarya , King, Rebecca L. , Boysen, Justin C. , Stenson, Mary, Carr, Ryan M. , Molina, Julian R. , Kapoor, Prashant , Kumar, Shaji , Yu, Jia , Wang, Liewei , Patnaik, Mrinal M. , Chen, Chen , Paludo, Jonas , Chen, C , Ravindran, Aishwarya , Mladek, Ann C , Carr, Ryan M , Hu, Chunling , Sarkaria, Jann N. , Feldman, Andrew L. , Manske, Michelle K. , Parikh, Sameer A. , Robinson, Steven I. , Boughey, Judy C. , Goetz, Matthew P. , Couch, Fergus J. , Witzig, Thomas E.

Mayo Clinic

Blood | November 3, 2020 | Volume: 137 | Issue: 4 | Pages: 513-523

10.1182/blood.2020009013 | PMID 33507295 Get It

Abstract Chromosome region maintenance protein 1 (CRM1) mediates protein export from the nucleus and is a new target for anticancer therapeutics. Broader application of KPT-330 (selinexor), a first-in-class CRM1 inhibitor recently approved for relapsed multiple myeloma and diffuse large B-cell lymphoma, have been limited by substantial toxicity. We discovered that salicylates markedly enhance the antitumor activity of CRM1 inhibitors by extending the mechanisms of action beyond CRM1 inhibition. Using salicylates in combination enables targeting of a range of blood cancers with a much lower dose of selinexor, thereby potentially mitigating prohibitive clinical adverse effects. Choline salicylate (CS) with low-dose KPT-330 (K+CS) had potent, broad activity across high-risk hematological malignancies and solid-organ cancers ex vivo and in vivo. The K+CS combination was not toxic to nonmalignant cells as compared with malignant cells and was safe without inducing toxicity to normal organs in mice. Mechanistically, compared with KPT-330 alone, K+CS suppresses the expression of CRM1, Rad51, and thymidylate synthase proteins, leading to more efficient inhibition of CRM1-mediated nuclear export, impairment of DNA-damage repair, reduced pyrimidine synthesis, cell-cycle arrest in S-phase, and cell apoptosis. Moreover, the addition of poly (ADP-ribose) polymerase inhibitors further potentiates the K+CS antitumor effect. K+CS represents a new class of therapy for multiple types of blood cancers and will stimulate future investigations to exploit DNA-damage repair and nucleocytoplasmic transport for cancer therapy in general.
Neural Antibody Testing in Patients with Suspected Autoimmune Encephalitis
Dubey, Divyanshu , Bhayana, Vipin , Pittock, Sean J. , Mills, John R. , Budhram, Adrian , Sechi, Elia , Pittock, S J , Dubey, Divyanshu , Flanagan, Eoin P. , Yang, Liju , McKeon, Andrew

Mayo Clinic

Clinical Chemistry | November 2, 2020 | Volume: 66 | Issue: 12 | Pages: 1496-1509

10.1093/clinchem/hvaa254 | PMID 33221892 Get It

Abstract Background Autoimmunity is an increasingly recognized cause of encephalitis with a similar prevalence to that of infectious etiologies. Over the past decade there has been a rapidly expanding list of antibody biomarker discoveries that have aided in the identification and characterization of autoimmune encephalitis. As the number of antibody biomarkers transitioning from the research setting into clinical laboratories has accelerated, so has the demand and complexity of panel-based testing. Clinical laboratories are increasingly involved in discussions related to test utilization and providing guidance on which testing methodologies provide the best clinical performance. Content To ensure optimal clinical sensitivity and specificity, comprehensive panel-based reflexive testing based on the predominant neurological phenotypic presentation (e.g., encephalopathy) is ideal in the workup of cases of suspected autoimmune neurological disease. Predictive scores based on the clinical workup can aid in deciding when to order a test. Testing of both CSF and serum is recommended with few exceptions. Appropriate test ordering and interpretation requires an understanding of both testing methodologies and performance of antibody testing in different specimen types. Summary This review discusses important considerations in the design and selection of neural antibody testing methodologies and panels. Increased collaboration between pathologists, laboratorians, and neurologists will lead to improved utilization of complex autoimmune neurology antibody testing panels.
Early technical pancreas failure in Simultaneous Pancreas–Kidney Recipients does not impact renal allograft outcomes
Das, Devika , Huskey, Janna L. , Harbell, Jack W. , Heilman, Raymond L. , Singer, Andrew L., Mathur, Amit K. , Neville, Matthew R., Morgan, Paige , Reddy, Kunam S. , Das, Devika M, Mathur, Amit , Jadlowiec, Caroline , Das, Devika , Morgan, Paige, Jadlowiec, Caroline C.

Mayo Clinic

Clinical Transplantation | November 1, 2020 | Volume: 35 | Issue: 1 | Pages: No page available

10.1111/ctr.14138 | PMID 33131111 Get It

AbstractEarly pancreas loss in simultaneous pancreas–kidney (SPK) transplants has been associated with longer perioperative recovery and reduced kidney allograft function. We assessed the impact of early pancreas allograft failure on transplant outcomes in a contemporary cohort of SPK patients (n = 218). Early pancreas allograft loss occurred in 12.8% (n = 28) of recipients. Delayed graft function (DGF) was more common (21.4% vs. 7.4%, p = 0.03) in the early pancreas loss group, but there were no differences in hospital length of stay (median 6.5 vs. 7.0, p = 0.22), surgical wound complications (p = 0.12), or rejection episodes occurring in the first year (p = 0.87). Despite differences in DGF, both groups had excellent renal function at 1 year post‐transplant (eGFR 64.1 ± 20.8 vs. 65.8 ± 22.9, p = 0.75). There were no differences in patient (HR 0.58, 95% CI 0.18–1.87, p = 0.26) or kidney allograft survival (HR 0.84, 95% CI 0.23–3.06, p = 0.77). One‐ and 2‐year protocol kidney biopsies were comparable between the groups and showed minimal chronic changes; the early pancreas loss group showed more cv changes at 2 years (p = 0.04). Current data demonstrate good outcomes and excellent kidney allograft function following early pancreas loss.
Association of Hospitalization with Long‐Term Cognitive Trajectories in Older Adults
Šprung, Juraj , Petersen, Ronald C. , Vassilaki, Maria , Martin, David P. , Schulte, Phillip J. , Hanson, Andrew C. , Schroeder, Darrell R. , Laporta, Mariana L. , White, Robert J. , Vemuri, Prashanthi , Vassilaki, Maria , Sprung, J , Vemuri, Prashanthi , Schroeder, Darrell , Knopman, David S. , Mielke, Michelle M. , Weingarten, Toby N. , White, Robert J., Warner, David O.

Mayo Clinic

Journal of the American Geriatrics Society | October 31, 2020 | Volume: 69 | Issue: 3 | Pages: 660-668

10.1111/jgs.16909 | PMID 33128387 Get It

IMPORTANCE Hospitalizations are associated with cognitive decline in older adults. OBJECTIVE To determine the association between hospitalization characteristics and the trajectory of cognitive function in older adults. DESIGN Population‐based longitudinal study of cognitive aging. SETTING Olmsted Medical Center and Mayo Clinic, the only centers in Olmsted County, Minnesota, with hospitalization capacity. PARTICIPANTS Individuals without dementia at baseline, with consecutive cognitive assessments from 2004 through 2017, and at least one visit after the age of 60. MEASUREMENTS The primary outcome was longitudinal changes in global cognitive z ‐score. Secondary outcomes were changes in four cognitive domains: memory, attention/executive function, language, and visuospatial skills. Hospitalization characteristics analyzed included elective versus nonelective, medical versus surgical, critical care versus no critical care admission, and long versus short duration admissions. RESULTS Of 4,587 participants, 1,622 had 1 and more hospital admission. Before hospitalization, the average slope of the global z ‐score was −0.031 units/year. After hospitalization, the rate of annual global z ‐score accelerated by −0.051 (95% CI = −0.057, −0.045) units, P < .001, resulting in an estimated annual slope after the first hospitalization of −0.082. The accelerated decline was found in all four cognitive domains (memory, visuospatial, language, and executive, all P < .001). The acceleration of the decline in global z ‐score following hospitalization was greater for medical compared to surgical hospitalizations (slope change following hospitalization = −0.064 vs −0.034 for medical vs surgical, P < .001), and nonelective compared to elective admissions (slope change following hospitalization = −0.075 vs −0.037 for nonelective vs elective, P < .001). The acceleration of cognitive decline was not different for hospitalization with intensive care unit admission versus not. CONCLUSIONS Hospitalization of older adults is associated with accelerated decline of global and domain‐specific cognitive domains, with the rate of decline dependent upon type of admission. The clinical impact of this accelerated decline will depend on the individual's baseline cognitive reserve and expected longevity.
Evaluation of Concordance Between Original Death Certifications and an Expert Panel Process in the Determination of Sudden Unexplained Death in Childhood
Gould, Laura , Lee, Joyce H. , Friedman, Daniel , Lear, Kelly, Maloney, Katherine F., Pinckard, J. Keith, Andrew, Thomas, Roman, Kristin, Landi, Kristen, Jarrell, Heather, Williamson, Alex , Downs, J. C. Upshaw, Pinneri, Kathy, William, Christopher , Maleszewski, Joseph J. , Reichard, R. Ross , Devinsky, Orrin , Lin, Peter , Devinsky, Orrin , Lin, Peter T. , Roman, Kristin

Mayo Clinic

JAMA Network Open | October 30, 2020 | Volume: 3 | Issue: 10 | Pages: e2023262

10.1001/jamanetworkopen.2020.23262 | PMID 33125496 Get It

Ascertainment of Delirium Status Using Natural Language Processing From Electronic Health Records
Fu, Sunyang , Lopes, Guilherme S. , Pagali, Sandeep R. , Thorsteinsdottir, Bjoerg , Rocca, Walter A. , Sohn, Sunghwan , Thorsteinsdottir, Bjorg , Rocca, Walter A , St Sauver, Jennifer, Pagali, Sandeep , Fu, Sunyang , Lopes, Guilherme S, LeBrasseur, Nathan K. , Wen, Andrew , Liu, Hongfang , Olson, Janet E. , Sauver, Jennifer L. St.

Mayo Clinic

The Journals of Gerontology: Series A | October 30, 2020 | Volume: 77 | Issue: 3 | Pages: 524-530

10.1093/gerona/glaa275 | PMID 35239951 Get It

Abstract Background Delirium is underdiagnosed in clinical practice and is not routinely coded for billing. Manual chart review can be used to identify the occurrence of delirium; however, it is labor-intensive and impractical for large-scale studies. Natural language processing (NLP) has the capability to process raw text in electronic health records (EHRs) and determine the meaning of the information. We developed and validated NLP algorithms to automatically identify the occurrence of delirium from EHRs. Methods This study used a randomly selected cohort from the population-based Mayo Clinic Biobank (N = 300, age ≥65). We adopted the standardized evidence-based framework confusion assessment method (CAM) to develop and evaluate NLP algorithms to identify the occurrence of delirium using clinical notes in EHRs. Two NLP algorithms were developed based on CAM criteria: one based on the original CAM (NLP-CAM; delirium vs no delirium) and another based on our modified CAM (NLP-mCAM; definite, possible, and no delirium). The sensitivity, specificity, and accuracy were used for concordance in delirium status between NLP algorithms and manual chart review as the gold standard. The prevalence of delirium cases was examined using International Classification of Diseases, 9th Revision (ICD-9), NLP-CAM, and NLP-mCAM. Results NLP-CAM demonstrated a sensitivity, specificity, and accuracy of 0.919, 1.000, and 0.967, respectively. NLP-mCAM demonstrated sensitivity, specificity, and accuracy of 0.827, 0.913, and 0.827, respectively. The prevalence analysis of delirium showed that the NLP-CAM algorithm identified 12 651 (9.4%) delirium patients, the NLP-mCAM algorithm identified 20 611 (15.3%) definite delirium cases, and 10 762 (8.0%) possible cases. Conclusions NLP algorithms based on the standardized evidence-based CAM framework demonstrated high performance in delineating delirium status in an expeditious and cost-effective manner.
Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling
Coomans, Marijke B , Dirven, Linda , Baumert, Brigitta G. , Bent, Martin J. van den , Bottomley, Andrew , Coens, Corneel , Gorlia, Thierry, Herrlinger, Ulrich , Keime-Guibert, Florence, Martinelli, Francesca , Sloan, Jeff A. , Talacchi, Andrea , Reijneveld, Jaap C. , Taphoorn, Martin , Weller, Michael , Wick, Wolfgang , van den Bent, Martin J , Aaronson, Neil K. , Brandes, Alba Ariela , Chinot, Olivier , Malmström, Annika , Stupp, Roger , Wick, Wolfgang

Mayo Clinic

Neuro-Oncology Advances | October 29, 2020 | Volume: 2 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdaa147 | PMID 33409496 Get It

Abstract Background Two methods combining survival and health-related quality of life (HRQoL) data in glioma trials to calculate the “net clinical benefit” were evaluated: Quality-adjusted effect sizes (QASES) and joint modeling (JM). Methods The net clinical benefit in two trials was calculated as proof of concept for other trials. With the QASES method, effect sizes for differences in progression-free survival (PFS) or overall survival (OS) and HRQoL between the experimental arm and standard treatment arm were calculated, while the relative emphasis placed on survival/HRQoL varied. JM allows simultaneous modeling of HRQoL and OS/PFS. Results In the EORTC 26951 trial, combined radiochemotherapy significantly prolonged OS (difference 11.7 months), but also resulted in more patients experiencing clinically relevant worsening (≥10 points) in appetite loss and nausea/vomiting shortly after treatment. Using QASES, the survival benefit of additional procarbazine, lomustine, and vincristine (PCV) decreased from 42.3 months to 29.5 and 28.2 months when accounting for appetite loss and nausea/vomiting, respectively. JM analyses resulted in a loss of the beneficial effect of additional PCV between 13% and 24% when adjusting for different HRQoL parameters. The EORTC 22033 trial showed no significant PFS difference between radiotherapy or temozolomide alone (46 vs 39 months), nor clinically relevant differences in HRQoL. JM analyses also showed no significant association between PFS and HRQoL scales/items, whereas QASES showed that temozolomide alone was more favorable when considering symptom burden (47–49 instead of 39 months). Conclusions Both methods resulted in different outcomes, but adjusting for the impact of treatment on HRQoL resulted in theoretically reduced survival benefits.
Impact of Urology Trainee Debt Levels on Future Practice Choices and Expectations
Harris, Andrew , Meeks, William, McKenna, P. G., Pruthi, Raj S. , Gonzalez, Chris, Schlossberg, Steven M., Gettman, Matthew T., North, Amanda , Gettman, Matthew, Fang, Raymond S. , Sadowski, Dan, Makarov, Danil V. , McKenna, Patrick, North, Amanda C.

Mayo Clinic

Urology Practice | October 28, 2020 | Volume: 8 | Issue: 2 | Pages: 303-308

10.1097/upj.0000000000000205 | PMID 37145622 Get It

Curating Archival Anatomic Pathology Material For Machine Learning Algorithm Development
Collins, Andrew , García, Joaquín J. , Collins, A, Norgan, Andrew P.

Mayo Clinic

American Journal of Clinical Pathology | October 28, 2020 | Volume: 154 | Issue: Supplement_1 | Pages: S124-S125

10.1093/ajcp/aqaa161.272 Get It

Abstract Introduction/Objective Advances in whole slide imaging have enabled the application of machine learning algorithms to anatomic pathology. In the current state, the development of accurate algorithms requires robust training data with correctly assigned diagnostic and classification labels. Increasingly, institutions have looked to their archival slides as a source of “ground truth” for algorithm development. However, the curation and use of archival data poses several challenges. Here, we share lessons learned from reviewing head and neck pathology consult cases spanning a 10- year period at Mayo Clinic Rochester. Methods Archived surgical pathology slides from 2,590 consult cases were reviewed. Clinical and demographic information was recorded for each case, including surgical date, surgical procedure, anatomic site, age, gender and diagnosis. Cases were excluded from the curated archive if there was insufficient volume or quality of tissue to render a specific diagnosis (141 cases, 5.6%). Slides with a range of tissue size and quality, from numerable laboratories were included in the curated archive. Selected cases were collated by anatomic site: ear, gnathic, larynx, nasopharynx, neck, oral cavity, oropharynx, salivary gland and sinonasal tract. Results Common diagnostic reconciliations (115 cases, 4.4%) fell within the following categories: (1) novel entities (59 cases, 2.3%), including biphenotypic sinonasal sarcoma and clear cell carcinoma; (2) novel classifications (21 cases, 0.8%), as seen in HPV-related oropharyngeal squamous cell carcinoma and polymorphous adenocarcinoma; and (3) novel grading schema (35 cases, 1.4%), as seen in keratinizing dysplasia and oropharyngeal malignancies. Conclusion Several nuances emerged in the process of reviewing slides, highlighting the need for continual amendment of any machine learning dataset over time. Curating anatomic pathology cases for machine learning algorithm development requires the recognition of emerging entities, with re-classification and re-grading as needed.
Physical and Metabolic Changes after Ileal Pouch-Anal Anastomosis: A Case Study
Erickson, Jacob L. , Molling, Paul , Stecker, Richie, Kerksick, Chad M. , Jagim, Andrew R. , Erickson, Jacob, Jagim, Andrew R , Kerksick, Chad M , Harty, Patrick S.

Mayo Clinic

Journal of Functional Morphology and Kinesiology | October 28, 2020 | Volume: 5 | Issue: 4 | Pages: 77

10.3390/jfmk5040077 | PMID 33467292 Get It

This case study examined changes in body composition, resting metabolic rate (RMR), aerobic capacity, and daily physical activity in a patient who had ulcerative colitis and underwent ileal pouch-anal anastomosis (IPAA) surgery. Body composition, RMR, and peak oxygen consumption (VO2peak) were assessed prior to surgery and four, eight, and 16 weeks after IPAA surgery. Daily physical activity data were extracted from a wrist-worn activity tracker preoperatively and 16 months postoperatively. At baseline, total body mass was 95.3 kg; body fat, 11.6%; lean body mass, 81.1 kg; RMR, 2416 kcal/d; and VO2peak, 42.7 mL/kg/min. All values decreased from baseline at four weeks postoperatively, body mass was 85.2 kg (−10.5%); body fat, 10.9% (−6.0%); lean body mass, 73.1 kg (−9.9%); RMR 2210 kcal/d (−8.5%) and VO2peak, 25.5 mL/kg/min (−40.3%). At 16 weeks postoperatively, most parameters were near their baseline levels (within 1–7%), exceptions were VO2peak, which was 20.4% below baseline, and RMR, which increased to nearly 20% above baseline. After the patient had IPAA surgery, his total and lean body masses, RMR, and aerobic capacity were markedly decreased. Daily physical activity decreased postoperatively and likely contributed to the decreased aerobic capacity, which may take longer to recover compared to body composition and RMR parameters.